生物活性 | |||
---|---|---|---|
描述 | PT2399 is a potent and selective HIF-2α antagonist that directly binds to the HIF-2α PAS B domain with an IC50 value of 6 nM. PT2399 has shown potent antitumour activity in vivo[1][2][3].PT2399 directly binds to the HIF-2α PAS B domain and impairs the ability of HIF-2α to bind to the aromatic hydrocarbon receptor nuclear transporter (ARNT)[2].At a concentration of 20 μM, PT2399 inhibited the proliferation of HIF-2α -/- 786-O cells and other cancer cell lines in which HIF-2α was undetectable, suggesting that PT2399 leads to off-target toxicity. PT2399 inhibited a variety of HIF-targeted genes in 786-O VHL-/- ccRCC cells, but not HIF-1α-specific target genes such as BNIP3[2]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.38mL 0.48mL 0.24mL |
11.92mL 2.38mL 1.19mL |
23.85mL 4.77mL 2.38mL |
参考文献 |
---|